BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2981438)

  • 41. Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat.
    Sodroski J; Rosen C; Wong-Staal F; Salahuddin SZ; Popovic M; Arya S; Gallo RC; Haseltine WA
    Science; 1985 Jan; 227(4683):171-3. PubMed ID: 2981427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential effects of retroviral long terminal repeats on interleukin-3 gene expression and autocrine transformation.
    Wang XY; McCubrey JA
    Leukemia; 1997 Oct; 11(10):1711-25. PubMed ID: 9324293
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complete nucleotide sequence of the genome of bovine leukemia virus: its evolutionary relationship to other retroviruses.
    Sagata N; Yasunaga T; Tsuzuku-Kawamura J; Ohishi K; Ogawa Y; Ikawa Y
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):677-81. PubMed ID: 2983308
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular studies of human T-cell leukemia virus and adult T-cell leukemia.
    Franchini G; Wong-Staal F; Gallo RC
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):63s-66s. PubMed ID: 6330224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).
    Sanchez-Pescador R; Power MD; Barr PJ; Steimer KS; Stempien MM; Brown-Shimer SL; Gee WW; Renard A; Randolph A; Levy JA
    Science; 1985 Feb; 227(4686):484-92. PubMed ID: 2578227
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction of viral and cellular factors with the HTLV-III LTR target sequences in vitro.
    Heisig V; Benter T; Josephs SF; Sadaie MR; Okamoto T; Gallo RC; Wong-Staal F
    Haematol Blood Transfus; 1987; 31():423-9. PubMed ID: 3481758
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The comparative molecular biology of HTLV-I and HTLV-II.
    Rosenblatt J; Wachsman W; Shimotohno K; Slamon D; Chen IS
    Princess Takamatsu Symp; 1984; 15():177-85. PubMed ID: 6100637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BLV and HTLV-I: their unique genomic structures and evolutionary relationship.
    Sagata N; Ikawa Y
    Princess Takamatsu Symp; 1984; 15():229-40. PubMed ID: 6085845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human protein binding to DNA sequences surrounding the human T-cell lymphotropic virus type-I long terminal repeat polyadenylation site.
    Levinger LF; Lautenberger JA
    Eur J Biochem; 1987 Aug; 166(3):519-26. PubMed ID: 3038544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure of a human retroviral sequence related to mouse mammary tumor virus.
    May FE; Westley BR
    J Virol; 1986 Nov; 60(2):743-9. PubMed ID: 3022006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.
    Sodroski J; Patarca R; Rosen C; Wong-Staal F; Haseltine W
    Science; 1985 Jul; 229(4708):74-7. PubMed ID: 2990041
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Twenty-one base pair repeat elements influence the ability of a Gal4-Tax fusion protein to transactivate the HTLV-I long terminal repeat.
    Connor LM; Oxman MN; Brady JN; Marriott SJ
    Virology; 1993 Aug; 195(2):569-77. PubMed ID: 8337832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genomes of evolutionarily divergent members of the human T-cell leukemia virus family (HTLV-I and HTLV-II) are highly conserved, especially in pX.
    Shaw GM; Gonda MA; Flickinger GH; Hahn BH; Gallo RC; Wong-Staal F
    Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4544-8. PubMed ID: 6087332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human T-cell leukemia virus types I and II exhibit different DNase I protection patterns.
    Altman R; Harrich D; Garcia JA; Gaynor RB
    J Virol; 1988 Apr; 62(4):1339-46. PubMed ID: 2831395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.
    Merezak C; Pierreux C; Adam E; Lemaigre F; Rousseau GG; Calomme C; Van Lint C; Christophe D; Kerkhofs P; Burny A; Kettmann R; Willems L
    J Virol; 2001 Aug; 75(15):6977-88. PubMed ID: 11435578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome.
    Shaw GM; Hahn BH; Arya SK; Groopman JE; Gallo RC; Wong-Staal F
    Science; 1984 Dec; 226(4679):1165-71. PubMed ID: 6095449
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human T-cell leukemia virus type I is a member of the African subtype of simian viruses (STLV).
    Watanabe T; Seiki M; Hirayama Y; Yoshida M
    Virology; 1986 Jan; 148(2):385-8. PubMed ID: 3002040
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bovine leukemia virus long terminal repeat variability: identification of single nucleotide polymorphisms in regulatory sequences.
    Pluta A; Rola-Łuszczak M; Douville RN; Kuźmak J
    Virol J; 2018 Oct; 15(1):165. PubMed ID: 30359262
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sequence homology of the simian retrovirus genome with human T-cell leukemia virus type I.
    Watanabe T; Seiki M; Tsujimoto H; Miyoshi I; Hayami M; Yoshida M
    Virology; 1985 Jul; 144(1):59-65. PubMed ID: 2998047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular characterization of human T-lymphotropic leukemia virus type III associated with the acquired immunodeficiency syndrome.
    Wong-Staal F; Hahn BH; Shaw GM; Arya SK; Harper M; Gonda M; Gilden R; Ratner L; Starcich B; Okamoto T
    Princess Takamatsu Symp; 1984; 15():291-300. PubMed ID: 6100646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.